NVCT Scorecard | Nuvectis Pharma, Inc.

Nuvectis Pharma, Inc. (NVCT) Scorecard

2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
2025-Q4: Total return Win; Revenue growth Lose; EPS growth Win.
2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Win.

40 QUARTERS × 3 ROAST BATTLES

10/120 All 120 Win/Lose results shown below

Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.

Trailing 1 year (4 quarters): 5 wins, 7 lossesLast fetched: 4 Sept 2026

Complete point ledger

Each cell identifies the missing side explicitly.

Quarter	Total return	Revenue growth	EPS growth
2026-Q21/3	WinNVCT / S&P 137.90% / 15.20%	LoseNVCT / S&P NVCT unavailable / 15.00%	LoseNVCT / S&P 11.97% / 50.40%
2026-Q11/3	WinNVCT / S&P 2.38% / -4.33%	LoseNVCT / S&P NVCT unavailable / 11.30%	LoseNVCT / S&P 15.93% / 27.70%
2025-Q42/3	WinNVCT / S&P 25.42% / 2.65%	LoseNVCT / S&P NVCT unavailable / 9.00%	WinNVCT / S&P 18.92% / 13.40%
2025-Q31/3	LoseNVCT / S&P -19.41% / 8.12%	LoseNVCT / S&P NVCT unavailable / 4.61%	WinNVCT / S&P 18.10% / 13.45%
2025-Q20/3	LoseNVCT / S&P -23.54% / 10.94%	LoseNVCT / S&P NVCT unavailable / 4.83%	LoseNVCT / S&P -9.30% / 10.63%
2025-Q11/3	WinNVCT / S&P 80.59% / -4.27%	LoseNVCT / S&P NVCT unavailable / 4.98%	LoseNVCT / S&P -19.86% / 10.57%
2024-Q40/3	LoseNVCT / S&P -13.99% / 2.41%	LoseNVCT / S&P NVCT unavailable / 5.25%	LoseNVCT / S&P -22.38% / 6.15%
2024-Q30/3	LoseNVCT / S&P -0.63% / 5.89%	LoseNVCT / S&P NVCT unavailable / 5.89%	LoseNVCT / S&P -22.67% / 6.11%
2024-Q20/3	LoseNVCT / S&P -22.80% / 4.28%	LoseNVCT / S&P NVCT unavailable / 5.38%	LoseNVCT / S&P -16.77% / 5.12%
2024-Q10/3	LoseNVCT / S&P -1.68% / 10.56%	LoseNVCT / S&P NVCT unavailable / 5.71%	LoseNVCT / S&P -2.76% / 5.59%
2023-Q40/3	LoseNVCT / S&P -35.30% / 11.69%	LoseNVCT / S&P NVCT unavailable / 6.81%	LoseNVCT / S&P -4.67% / 7.78%
2023-Q31/3	LoseNVCT / S&P -19.29% / -3.27%	LoseNVCT / S&P NVCT unavailable / 7.52%	WinNVCT / S&P 0.00% / -5.03%
2023-Q21/3	WinNVCT / S&P 21.82% / 8.74%	LoseNVCT / S&P NVCT unavailable / 9.50%	LoseNVCT / S&P -26.89% / -8.57%
2023-Q11/3	WinNVCT / S&P 74.80% / 7.50%	LoseNVCT / S&P NVCT unavailable / 10.77%	LoseNVCT / S&P -55.66% / -15.69%
2022-Q40/3	LoseNVCT / S&P 5.78% / 7.56%	LoseNVCT / S&P NVCT unavailable / 11.88%	LoseNVCT / S&P -48.98% / -17.99%
2022-Q30/3	LoseNVCT / S&P -36.70% / -4.88%	LoseNVCT / S&P NVCT unavailable / 13.47%	LoseNVCT / S&P NVCT unavailable / -1.41%
2022-Q21/3	WinNVCT / S&P 51.15% / -16.10%	LoseNVCT / S&P NVCT unavailable / 13.71%	LoseNVCT / S&P NVCT unavailable / 11.04%
2022-Q10/3	LoseNVCT / S&P NVCT unavailable / -4.60%	LoseNVCT / S&P NVCT unavailable / 15.97%	LoseNVCT / S&P NVCT unavailable / 42.23%
2021-Q40/3	LoseNVCT / S&P NVCT unavailable / 11.03%	LoseNVCT / S&P NVCT unavailable / 15.00%	LoseNVCT / S&P NVCT unavailable / 96.40%
2021-Q30/3	LoseNVCT / S&P NVCT unavailable / 0.58%	LoseNVCT / S&P NVCT unavailable / 10.77%	LoseNVCT / S&P NVCT unavailable / 69.42%
2021-Q20/3	LoseNVCT / S&P NVCT unavailable / 8.55%	LoseNVCT / S&P NVCT unavailable / 6.58%	LoseNVCT / S&P NVCT unavailable / 51.81%
2021-Q10/3	LoseNVCT / S&P NVCT unavailable / 6.17%	LoseNVCT / S&P NVCT unavailable / -1.06%	LoseNVCT / S&P NVCT unavailable / 7.39%
2020-Q40/3	LoseNVCT / S&P NVCT unavailable / 12.15%	LoseNVCT / S&P NVCT unavailable / -3.72%	LoseNVCT / S&P NVCT unavailable / -33.42%
2020-Q30/3	LoseNVCT / S&P NVCT unavailable / 8.93%	LoseNVCT / S&P NVCT unavailable / -2.04%	LoseNVCT / S&P NVCT unavailable / -27.10%
2020-Q20/3	LoseNVCT / S&P NVCT unavailable / 20.54%	LoseNVCT / S&P NVCT unavailable / -0.46%	LoseNVCT / S&P NVCT unavailable / -27.11%
2020-Q10/3	LoseNVCT / S&P NVCT unavailable / -19.60%	LoseNVCT / S&P NVCT unavailable / 3.47%	LoseNVCT / S&P NVCT unavailable / -14.75%
2019-Q40/3	LoseNVCT / S&P NVCT unavailable / 9.07%	LoseNVCT / S&P NVCT unavailable / 5.36%	LoseNVCT / S&P NVCT unavailable / 2.99%
2019-Q30/3	LoseNVCT / S&P NVCT unavailable / 1.70%	LoseNVCT / S&P NVCT unavailable / 5.02%	LoseNVCT / S&P NVCT unavailable / 0.21%
2019-Q20/3	LoseNVCT / S&P NVCT unavailable / 4.30%	LoseNVCT / S&P NVCT unavailable / 6.64%	LoseNVCT / S&P NVCT unavailable / 8.65%
2019-Q10/3	LoseNVCT / S&P NVCT unavailable / 13.65%	LoseNVCT / S&P NVCT unavailable / 8.12%	LoseNVCT / S&P NVCT unavailable / 14.29%
2018-Q40/3	LoseNVCT / S&P NVCT unavailable / -13.52%	LoseNVCT / S&P NVCT unavailable / 9.05%	LoseNVCT / S&P NVCT unavailable / 18.23%
2018-Q30/3	LoseNVCT / S&P NVCT unavailable / 7.71%	LoseNVCT / S&P NVCT unavailable / 10.21%	LoseNVCT / S&P NVCT unavailable / 19.06%
2018-Q20/3	LoseNVCT / S&P NVCT unavailable / 3.43%	LoseNVCT / S&P NVCT unavailable / 9.03%	LoseNVCT / S&P NVCT unavailable / 14.46%
2018-Q10/3	LoseNVCT / S&P NVCT unavailable / -0.76%	LoseNVCT / S&P NVCT unavailable / 7.68%	LoseNVCT / S&P NVCT unavailable / 12.46%
2017-Q40/3	LoseNVCT / S&P NVCT unavailable / 6.64%	LoseNVCT / S&P NVCT unavailable / 7.03%	LoseNVCT / S&P NVCT unavailable / 13.82%
2017-Q30/3	LoseNVCT / S&P NVCT unavailable / 4.48%	LoseNVCT / S&P NVCT unavailable / 5.68%	LoseNVCT / S&P NVCT unavailable / 17.57%
2017-Q20/3	LoseNVCT / S&P NVCT unavailable / 3.09%	LoseNVCT / S&P NVCT unavailable / 4.83%	LoseNVCT / S&P NVCT unavailable / 17.74%
2017-Q10/3	LoseNVCT / S&P NVCT unavailable / 6.07%	LoseNVCT / S&P NVCT unavailable / 3.67%	LoseNVCT / S&P NVCT unavailable / 13.32%
2016-Q40/3	LoseNVCT / S&P NVCT unavailable / 3.82%	LoseNVCT / S&P NVCT unavailable / 2.09%	LoseNVCT / S&P NVCT unavailable / 7.05%
2016-Q30/3	LoseNVCT / S&P NVCT unavailable / 3.85%	LoseNVCT / S&P NVCT unavailable / 0.20%	LoseNVCT / S&P NVCT unavailable / -3.15%

Dividend-reinvested, split-adjusted total return

1Y · 2025-08-29 to 2026-08-27

Metric	NVCT total return	S&P 500 Total Return Index
Total return	283.99%	20.78%
Annualized return	283.99%	20.78%

5Y · 2022-02-04 to 2026-08-27

Metric	NVCT total return	S&P 500 Total Return Index
Total return	675.08%	83.14%
Annualized return	50.62%	12.86%

10Y · 2022-02-04 to 2026-08-27

Metric	NVCT total return	S&P 500 Total Return Index
Total return	675.08%	319.30%
Annualized return	22.73%	15.41%

Calculation rules

window: Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
return Basis: Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
point Rule: Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
frequency: Quarter endpoints only.
fundamentals: Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
non Scoring

Snapshot captured 2026-09-04.

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Verastem, Inc. (VSTM)	United States	$0.706B	-1.71
IRONWOOD PHARMACEUTICALS INC (IRWD)	United States	$0.694B	5.37
Climb Bio, Inc. (CLYM)	United States	$0.683B	-13.03
COLLEGIUM PHARMACEUTICAL, INC (COLL)	United States	$0.737B	24.57
ZEVRA THERAPEUTICS, INC. (ZVRA)	United States	$0.668B	14.61
Faeth Therapeutics, Inc. (FTH)	United States	$0.750B
BlossomHill Therapeutics, Inc. (BLSM)	United States	$0.647B
Design Therapeutics, Inc. (DSGN)	United States	$0.766B	-12.78
Shattuck Labs, Inc. (STTK)	United States	$0.634B	-13.30
Wave Life Sciences, Inc. (WVE)		$0.780B	-5.56